OSR Holdings Gets Nasdaq Notice on Trading Issues
10 Sep 2025 //
PR NEWSWIRE
OSR Holdings to Acquire Noninvasive Glucose Tech Pioneer Woori IO
24 Jul 2025 //
PR NEWSWIRE
OSR Holdings Names Andreas as Vaximm AG`s Chief Medical Officer
15 Jul 2025 //
PR NEWSWIRE
Darnatein, OSR Company, Expands IP Protection for Arthritis Tech
09 Apr 2025 //
PR NEWSWIRE
Vaximm AG Announces Phase 2a Trial Results for Glioblastoma
26 Mar 2025 //
PR NEWSWIRE
OSR, SillaJen MOU For US Therapeutic Development
22 Apr 2024 //
PR NEWSWIRE